Using Medical Imaging as a Catalyst for Oncology Research

The use of medical imaging in oncology trials is growing rapidly, and it plays an essential role in determining go/no-go decisions and demonstrating proof-of-concept in early phases, as well as primary or secondary endpoints in other phases. Thus, the importance of an efficient and reliable imaging workflow is crucial. 

Unfortunately, processes and systems for managing medical images are generally decoupled from other systems and processes, leading to numerous queries, time-consuming data reconciliation, and other challenges that ultimately delay and negatively impact these trials. 

In our complimentary webinar, hear from special guest speakers Robert Ford, M.D., Pat Byrne, and Dan Braga, as they explore how Medidata Rave Imaging is helping oncology trials overcome these challenges by:

  • Reducing your study startup timelines 
  • Reducing 86% of your imaging related queries
  • Providing the visibility and transparency of real-time reporting
  • Ensuring and maintaining your GDPR and HIPAA compliance

Webinar Details:

Date: Tuesday, June 19, 2018
Time: 11:00 AM


Robert R. Ford, M.D. received his B.S. degree from Rutgers University in 1979 and his M.D. degree from Robert Wood Johnson Medical School in 1983. He completed an internship in Internal Medicine at Robert Wood Johnson University Medical Center and University Medical Center at Princeton. From 1984 to 1988 he completed a residency in Diagnostic Radiology at Cornell University Medical Center-New York Hospital, Memorial Sloane Kettering Cancer Center, and the Hospital for Special Surgery.

Dr. Ford was an author of the Response Evaluation Criteria of Solid Tumors (RECIST 1.1) an internationally accepted Response Criteria that is used to standardize patient response to therapy. In January 2014, Dr. Ford founded Clinical Trials Imaging Consulting LLC, a consulting company specializing in providing consulting services in the area of medical imaging (radiology) and clinical trials to the Pharmaceutical and Biotechnology industry.

Dr. Ford has certification by the National Board of Medical Examiners. He is Board Certified in Diagnostic Radiology and has a Certificate of Added Qualifications in Neuroradiology from the American Board of Radiology.

Pat Byrne

Industry Experience Overview: Pat Byrne has 28 years of clinical research experience, all in the medical device sector, in both Sponsor and CRO organizations. Her professional experience includes ten years of experience in various nursing roles. Ms. Byrne’s experience includes work as a CRA in a medical device company monitoring endovascular stent trials in various indications. In addition, Ms. Byrne held a training role in a medical device company specializing in urology, where she was first responsible for training Europe-wide urologists in the use of stents for urethral stricture and benign prostatic hyperplasia (BPH), and subsequently for training surgeons on surgical procedures for implantable class 3 devices. Ms. Byrne gained experience in a medical device specialist CRO as a CRA and Project Manager, and on the Sponsor side, in various CRA, management and line management roles

Therapeutic Experience: Ms. Byrne’s therapeutic and device experience includes dermatology, mammoplasty, breast cancer detection, bariatrics, soft tissue support, urology and uro-gynecology, gastroenterology,  cardiovascular, neurology, imaging, oncology and musculoskeletal indications.

Dan Braga is the senior director for medical imaging solutions at Medidata Solutions. Dan works with sponsors, CROs, core labs, and sites to adopt medical image technologies to help automate image acquisition, distribution, assessment, and data collection. Prior to Medidata, Dan was one of the co-founders of Intelemage, a medical image management and workflow company later acquired by Medidata. Prior to Intelemage, Dan worked in various product management, operational and sales roles with healthcare technology companies such as GE Healthcare, PocketScript, and WebMD.